LM initiation 3 months† N=23 6 months‡ N=20
  CD4 count CD4% CD4 count CD4 % CD4 count CD4 %
1 520 18 347 14.2    
2 1512 35.4 1540 36.8 1355 30.4
3 627 19.65 610 22.3    
4 534 26.2 476 19.3 358 15.6
5 1984 32.1 1648 31.3 1462 33.6
6 527 25.4 569 24.6 549 22.5
7 578 29.4 380 24 447 23.2
8 500 30.6 546 29.7 755 30.4
9 84 3.4 8 0.58 Stopped LM after 5 months
10 475 11.2 244 10 123 3.8
11 994 41.5 759 30.2 761 30.4
12 341 10.8 316 13.6 Stopped LM after 4 months
13 547 16.3 425 14.7 478 15.3
14 895 21.53 1188 13.09 748 17.43
15 1745 14.69     1066 16.35
16 1730 25.36 1101 30 1166 29.94
17 1005 34.35 371 28.54 186 13.52
18 752 28.96 752 28.9 540 23.89
19 1239 19.8   Defaulted follow-up after 3 months
20 982 17.9     872 19.41
21 285 18.4     285 19.8
22 1632 33.7 478 16.6 1136 22.7
23 715 34.8 477 29.2 649 31.6
* LM = Lamivudine monotherapy
† 4/23 did not have a CD4 measure performed at 3 months of follow-up.
‡ 2/20 who remained on LM at 6 months did not have a CD4 measure performed.
Table 2: CD4 count and CD4 percentage at LM* initiation and at 3 and 6 months of LM.